Cargando…

SHAPE-enabled fragment-based ligand discovery for RNA

The transcriptome represents an attractive but underused set of targets for small-molecule ligands. Here, we devise a technology that leverages fragment-based screening and SHAPE-MaP RNA structure probing to discover small-molecule fragments that bind an RNA structure of interest. We identified frag...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeller, Meredith J., Favorov, Oleg, Li, Kelin, Nuthanakanti, Ashok, Hussein, Dina, Michaud, Auréliane, Lafontaine, Daniel A., Busan, Steven, Serganov, Alexander, Aubé, Jeffrey, Weeks, Kevin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171761/
https://www.ncbi.nlm.nih.gov/pubmed/35561226
http://dx.doi.org/10.1073/pnas.2122660119
_version_ 1784721737937584128
author Zeller, Meredith J.
Favorov, Oleg
Li, Kelin
Nuthanakanti, Ashok
Hussein, Dina
Michaud, Auréliane
Lafontaine, Daniel A.
Busan, Steven
Serganov, Alexander
Aubé, Jeffrey
Weeks, Kevin M.
author_facet Zeller, Meredith J.
Favorov, Oleg
Li, Kelin
Nuthanakanti, Ashok
Hussein, Dina
Michaud, Auréliane
Lafontaine, Daniel A.
Busan, Steven
Serganov, Alexander
Aubé, Jeffrey
Weeks, Kevin M.
author_sort Zeller, Meredith J.
collection PubMed
description The transcriptome represents an attractive but underused set of targets for small-molecule ligands. Here, we devise a technology that leverages fragment-based screening and SHAPE-MaP RNA structure probing to discover small-molecule fragments that bind an RNA structure of interest. We identified fragments and cooperatively binding fragment pairs that bind to the thiamine pyrophosphate (TPP) riboswitch with millimolar to micromolar affinities. We then used structure-activity relationship information to efficiently design a linked-fragment ligand, with no resemblance to the native ligand, with high ligand efficiency and druglikeness, that binds to the TPP thiM riboswitch with high nanomolar affinity and that modulates RNA conformation during cotranscriptional folding. Principles from this work are broadly applicable, leveraging cooperativity and multisite binding, for developing high-quality ligands for diverse RNA targets.
format Online
Article
Text
id pubmed-9171761
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher National Academy of Sciences
record_format MEDLINE/PubMed
spelling pubmed-91717612022-11-15 SHAPE-enabled fragment-based ligand discovery for RNA Zeller, Meredith J. Favorov, Oleg Li, Kelin Nuthanakanti, Ashok Hussein, Dina Michaud, Auréliane Lafontaine, Daniel A. Busan, Steven Serganov, Alexander Aubé, Jeffrey Weeks, Kevin M. Proc Natl Acad Sci U S A Biological Sciences The transcriptome represents an attractive but underused set of targets for small-molecule ligands. Here, we devise a technology that leverages fragment-based screening and SHAPE-MaP RNA structure probing to discover small-molecule fragments that bind an RNA structure of interest. We identified fragments and cooperatively binding fragment pairs that bind to the thiamine pyrophosphate (TPP) riboswitch with millimolar to micromolar affinities. We then used structure-activity relationship information to efficiently design a linked-fragment ligand, with no resemblance to the native ligand, with high ligand efficiency and druglikeness, that binds to the TPP thiM riboswitch with high nanomolar affinity and that modulates RNA conformation during cotranscriptional folding. Principles from this work are broadly applicable, leveraging cooperativity and multisite binding, for developing high-quality ligands for diverse RNA targets. National Academy of Sciences 2022-05-13 2022-05-17 /pmc/articles/PMC9171761/ /pubmed/35561226 http://dx.doi.org/10.1073/pnas.2122660119 Text en Copyright © 2022 the Author(s). Published by PNAS. https://creativecommons.org/licenses/by-nc-nd/4.0/This article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Biological Sciences
Zeller, Meredith J.
Favorov, Oleg
Li, Kelin
Nuthanakanti, Ashok
Hussein, Dina
Michaud, Auréliane
Lafontaine, Daniel A.
Busan, Steven
Serganov, Alexander
Aubé, Jeffrey
Weeks, Kevin M.
SHAPE-enabled fragment-based ligand discovery for RNA
title SHAPE-enabled fragment-based ligand discovery for RNA
title_full SHAPE-enabled fragment-based ligand discovery for RNA
title_fullStr SHAPE-enabled fragment-based ligand discovery for RNA
title_full_unstemmed SHAPE-enabled fragment-based ligand discovery for RNA
title_short SHAPE-enabled fragment-based ligand discovery for RNA
title_sort shape-enabled fragment-based ligand discovery for rna
topic Biological Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171761/
https://www.ncbi.nlm.nih.gov/pubmed/35561226
http://dx.doi.org/10.1073/pnas.2122660119
work_keys_str_mv AT zellermeredithj shapeenabledfragmentbasedliganddiscoveryforrna
AT favorovoleg shapeenabledfragmentbasedliganddiscoveryforrna
AT likelin shapeenabledfragmentbasedliganddiscoveryforrna
AT nuthanakantiashok shapeenabledfragmentbasedliganddiscoveryforrna
AT husseindina shapeenabledfragmentbasedliganddiscoveryforrna
AT michaudaureliane shapeenabledfragmentbasedliganddiscoveryforrna
AT lafontainedaniela shapeenabledfragmentbasedliganddiscoveryforrna
AT busansteven shapeenabledfragmentbasedliganddiscoveryforrna
AT serganovalexander shapeenabledfragmentbasedliganddiscoveryforrna
AT aubejeffrey shapeenabledfragmentbasedliganddiscoveryforrna
AT weekskevinm shapeenabledfragmentbasedliganddiscoveryforrna